• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌患者腋窝淋巴结对纳米胶体和多克隆免疫球蛋白摄取分数的测量。

Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer.

作者信息

Fowler J Charlotte, Solanki Chandra K, Barber Robert W, Swift E Anna, Guenther Ilonka, Ballinger James R, Purushotham Arnie D, Peters A Michael

机构信息

Department of Nuclear Medicine, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.

出版信息

Nucl Med Commun. 2004 Sep;25(9):935-40. doi: 10.1097/00006231-200409000-00011.

DOI:10.1097/00006231-200409000-00011
PMID:15319599
Abstract

BACKGROUND

99mTc nanocolloid (99mTc-NC) is the most widely used tracer for lymphoscintigraphy, although others have been proposed, including radiolabelled proteins such as human serum albumin and polyclonal human immunoglobulin G (HIG). The extraction fraction of such tracers by individual nodes is clearly important but has not previously been measured in humans.

METHODS

Patients scheduled for axillary clearance surgery (three groups) received dual-labelled radiotracers 2-4 h before surgery: group 1 (3 patients) received 99mTc-NC (10 MBq) and 111In-HIG (2 MBq) as a mixture (0.2 ml) into the breast parenchyma above the primary tumour; group 2 (3 patients) received 99mTc-HIG (10 MBq) and 111In-HIG (2 MBq) as a mixture (0.2 ml) into the breast parenchyma above the primary tumour; and group 3 (4 patients) received 99mTc-HIG (10 MBq) and 111In-HIG (2 MBq) separately (both 0.2 ml) into the breast parenchyma above the tumour and the intradermal plane at the areola. All resected nodes were counted for Tc and In in a well-type scintillation counter. In group 1, nodes were ranked according to their Tc uptake. In groups 2 and 3, nodes were ranked separately according to their respective Tc and In uptakes. If nodes are arranged in linear order and each node extracts a constant fraction of incoming tracer, then the activity in the nodes would decrease exponentially with an individual nodal extraction fraction, E, equal to 1-e(-k), where k is the rate constant of decrease.

RESULTS

In the first group, 99mTc-NC and 111In-HIG identified the same sentinel and second echelon nodes. The observed decrease in nodal activity was exponential in all groups, at least for the first five nodes. Average values for E, based on the first five nodes were 0.69 (range 0.57-0.89; n=3) for 99mTc-NC and 0.45 (0.15-0.70; n=17) for HIG (irrespective of label) (Wilcoxon rank sum, P=0.02). With respect to HIG, there was no significant difference in E between 99mTc and 111In or between deep and superficial injections in group 3.

CONCLUSION

Although HIG has an extraction fraction less than 99mTc-NC, the value of E is still high enough to make HIG a useful tracer for lymphoscintigraphy, especially for identifying second echelon nodes in addition to sentinel nodes and for imaging lymphatic vessels as well as lymph nodes.

摘要

背景

99mTc纳米胶体(99mTc-NC)是淋巴闪烁显像中使用最广泛的示踪剂,尽管也有人提出使用其他示踪剂,包括放射性标记的蛋白质,如人血清白蛋白和多克隆人免疫球蛋白G(HIG)。单个淋巴结对这些示踪剂的摄取分数显然很重要,但此前尚未在人体中进行测量。

方法

计划进行腋窝清扫手术的患者(三组)在手术前2-4小时接受双标记放射性示踪剂:第一组(3例患者)将99mTc-NC(10MBq)和111In-HIG(2MBq)混合(0.2ml)注入原发肿瘤上方的乳腺实质;第二组(3例患者)将99mTc-HIG(10MBq)和111In-HIG(2MBq)混合(0.2ml)注入原发肿瘤上方的乳腺实质;第三组(4例患者)将99mTc-HIG(10MBq)和111In-HIG(2MBq)分别(均为0.2ml)注入肿瘤上方乳腺实质和乳晕处的皮内平面。所有切除的淋巴结在井型闪烁计数器中进行Tc和In计数。在第一组中,根据淋巴结的Tc摄取量进行排序。在第二组和第三组中,分别根据各自的Tc和In摄取量进行排序。如果淋巴结按线性顺序排列,且每个淋巴结摄取进入示踪剂的恒定分数,那么淋巴结中的活性将呈指数下降,单个淋巴结摄取分数E等于1-e(-k),其中k是下降速率常数。

结果

在第一组中,99mTc-NC和111In-HIG识别出相同的前哨淋巴结和第二梯队淋巴结。在所有组中,观察到的淋巴结活性下降呈指数形式,至少在前五个淋巴结中是这样。基于前五个淋巴结的E平均值,99mTc-NC为0.69(范围0.57-0.89;n=3),HIG(无论标记如何)为0.4(0.15-0.70;n=17)(Wilcoxon秩和检验,P=0.02)。对于HIG,在第三组中,99mTc和111In之间或深部和浅部注射之间的E没有显著差异。

结论

尽管HIG的摄取分数低于99mTc-NC,但E值仍然足够高,使HIG成为淋巴闪烁显像的有用示踪剂,特别是用于识别除前哨淋巴结外的第二梯队淋巴结以及对淋巴管和淋巴结进行成像。

相似文献

1
Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer.乳腺癌患者腋窝淋巴结对纳米胶体和多克隆免疫球蛋白摄取分数的测量。
Nucl Med Commun. 2004 Sep;25(9):935-40. doi: 10.1097/00006231-200409000-00011.
2
Axillary lymph node drainage pathways from intradermal and intraparenchymal breast planes.从皮内和实质乳腺平面引流腋窝淋巴结的途径。
J Surg Res. 2010 Jun 1;161(1):69-75. doi: 10.1016/j.jss.2009.01.003. Epub 2009 Jan 31.
3
Finding an optimal method for imaging lymphatic vessels of the upper limb.寻找一种用于上肢淋巴管成像的最佳方法。
Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):555-63. doi: 10.1007/s00259-003-1399-3. Epub 2004 Jan 14.
4
Comparison of efficacy of Tc-99m HIG and Tc-99m nanocolloid on sentinel lymph node mapping in patients with breast cancer.锝-99m 人免疫球蛋白(Tc-99m HIG)与锝-99m 纳米胶体在乳腺癌患者前哨淋巴结定位中的疗效比较。
Nucl Med Commun. 2010 Oct;31(10):903-9. doi: 10.1097/MNM.0b013e32833dedbf.
5
Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.乳晕下注射99m锝纳米胶体可为先前对原发性肿瘤进行过处理的乳腺癌患者腋窝淋巴结肿瘤状态提供可靠数据:一项针对117例患者的前瞻性研究。
Eur J Nucl Med Mol Imaging. 2004 May;31(5):671-5. doi: 10.1007/s00259-003-1447-z. Epub 2004 Jan 27.
6
Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.通过单次瘤内注射进行乳腺淋巴闪烁造影以识别前哨淋巴结的评估。
J Nucl Med. 2000 Sep;41(9):1500-6.
7
Measurement of lymphatic function with technetium-99m-labelled polyclonal immunoglobulin.用锝-99m标记的多克隆免疫球蛋白测量淋巴功能。
Eur J Nucl Med. 1999 May;26(5):504-10. doi: 10.1007/s002590050418.
8
Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.在接受前哨淋巴结活检的乳腺癌患者中,注射经滤过的锝-99m硫胶体后进行早期与延迟乳腺淋巴闪烁显像的淋巴引流模式。
Clin Nucl Med. 2005 Jan;30(1):11-5. doi: 10.1097/00003072-200501000-00003.
9
An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.早期乳腺癌诊断的一种原创方法:对不可触及病变和前哨淋巴结定位使用相同的放射性药物。
Eur J Nucl Med. 2001 Nov;28(11):1589-96. doi: 10.1007/s002590100601.
10
Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT).多中心、多灶性乳腺癌的淋巴闪烁显像和 SPECT/CT:每个肿瘤是否具有单独的引流模式?荷兰多中心研究(MULTISENT)的结果。
Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1137-43. doi: 10.1007/s00259-012-2131-y. Epub 2012 Apr 24.